This is groundbreaking news folks, just last week China's "State Food and Drug -Administration warned hepatitis B carriers not to buy a "cheating drug" online, which claims it can help them pass hepatitis B tests, but could actually be lethal."
Why would anyone buy a dangerous drug that would hinder HBV testing?
Here's why, this statement followed;"China's ministries of human resources and social security, education and health yesterday issued a joint statement, reiterating the government's ban on tests for hepatitis B by prospective employers."
In China an employer screens for HBV, of the 350 million individuals worldwide infected with hepatitis B, one-third reside in China.
Hospital pays out over illegal hepatitis check
A MAN has finally received 25,000 yuan (US$3,803) compensation from a hospital in Southwest China, the highest amount so far, in a case against hepatitis discrimination after losing the lawsuit the previous four times.
After mediation conducted by Guiyang City Intermediate People's Court in Guizhou Province, the hospital affiliated to Guiyang Medical University agreed to pay 25,000 yuan to the plaintiff, going by the alias Jing Xin, for having been checked for hepatitis B in pre-employment physicals, a practice banned to protect the rights of virus carriers.
Jing went to the hospital to have a health check-up organized by his potential employer in September 2008. Without getting Jing's consent, the hospital tested him for the virus and diagnosed him with chronic hepatitis B. The test result was sent to the employer and Jing was turned down for the job.
The Ministry of Human Resources and Social Security, the Ministry of Education, and the Ministry of Health jointly issued a notice forbidding hospitals to do the test in pre-employment medical check ups in 2010.
Jing sued his potential employer for discrimination in December 2008, but he lost the trial and also the appeal.
He brought legal action against the hospital for conducting an illegal check for hepatitis B and for invasion of his privacy in July 2010, but Yunyan District People's Court rejected the lawsuit in the first trial.
http://www.shanghaidaily.com/article/?id=466607
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Friday, March 18, 2011
Hospital pays out over illegal hepatitis check
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment